DAF-2 DA (DMSO solution), fluorescent nitric oxide probe (ab146631)
Key features and details
- Fluorescent nitric oxide probe; membrane-permeable
- CAS Number: 205391-02-2
- Purity: > 98%
- Supplied in DMSO (5 mM)
- Form / State: Liquid
- Source: Synthetic
製品の概要
-
製品名
DAF-2 DA (DMSO solution), fluorescent nitric oxide probe -
製品の詳細
Fluorescent nitric oxide probe; membrane-permeable -
精製度
> 98% -
特記事項
This product is manufactured by BioVision, an Abcam company and was previously called 2753 DAF-2 diacetate, EZSolution™. 2753-100 is the same size as the 100 µg size of ab146631.
-
CAS 番号
205391-02-2 -
構造式
製品の特性
-
励起波長
485nm -
蛍光波長
538nm -
体系名
(6'-Acetyloxy-5,6-diamino-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate -
分子量
446.41 -
分子式
C24H18N2O7 -
PubChem 登録番号
6603693 -
保存方法
Store at -20°C. Store In the Dark. Store under desiccating conditions. This product is air and light sensitive and impurities can occur as a result of air oxidation or due to metabolism by microbes. -
溶解性
Supplied in DMSO (5 mM) -
使用に関する注意
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES 線形表記
CC(=O)OC1=CC2=C(C=C1)C3(C4=C(O2)C=C(C=C4)OC(=O)C)C5=CC(=C(C=C5C(=O)O3)N)N -
由来
Synthetic
-
研究分野
画像
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (1)
ab146631 は 1 報の論文で使用されています。
- Bochenek ML et al. EPCR-PAR1 biased signaling regulates perfusion recovery and neovascularization in peripheral ischemia. JCI Insight 7:N/A (2022). PubMed: 35700057